Proton Pump Inhibitors

Nexium, Prilosec & Prevacid – PPIs

On May 25, 2010, the Food and Drug Administration warned that commonly used heartburn medications known as Proton pump inhibitors (PPIs) may increase the risk of fractures of the hip, wrist and spine in long term use.   As a result of these warnings, the labels on these medications will be changed.  These actions followed an FDA review of certain studies that reported increased risks of these fractures through epidemiology.   

PPIs available for prescription include:
  • Nexium (esomeprazole)
  • Dexilant (dexlansoprazole)
  • Prilosec Zegerid (omeprazole)
  • Prevacid (lansoprazole)
  • Protonix (pantoprazole) and
  • Acihpex (rabeprazole).
Over the counter (OTC) PPIs include:
  • Prilosec OTC,
  • Zegerid OTC, and
  • Prevacid 24HR
Based on the news reports and at least one study, the greatest risk appears to concern adults older than 50 and use in high doses or for more than a year. 

A University of Pennsylvania study indicated that PPIs increase the risk of fractures as a result of the inhibition of calcium absorption by the body.  One author (Dr. Yang) noted that taking PPIs for more than one year provided a more than 40 percent increased the risk of hip fracture and high dose users were exposed to more than 2.5 times the risk. According to an ABC News report, a FDA spokesperson stated that the OTC versions are being relabeled as a precautionary step.

If you are over the age of 50 and have experienced a fracture while taking a heartburn medication, please contact defective drug lawyer Mike Sudekum for a free discussion of your case.